Genus Price Target Raised to $18.89 at Panmure Gordon (GNS)
Research analysts at Panmure Gordon lifted their target price on shares of Genus (LON: GNS) from $17.98 (1190 GBX) to $18.89 (1250 GBX) in a report released on Monday. The firm currently has a “sell” rating on the stock.
Genus traded down 2.13% on Monday, hitting GBX 1425.00. Genus has a 1-year low of GBX 1129.00 and a 1-year high of GBX 1535.00. The stock’s 50-day moving average is currently GBX 1424.. The company’s market cap is £857.1 million.
Several other analysts have also recently commented on the stock. Analysts at N+1 Singer reiterated a “buy” rating on shares of Genus in a research note to investors on Monday. They now have a $25.36 price target on the stock. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of Genus in a research note to investors on Monday. They now have a $20.55 price target on the stock.
Genus plc is a United Kingdom-based company. The Company is engaged in applying quantitative genetics and biotechnology to animal breeding in the bovine and porcine sectors.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.